Indeed, the same research group reported in a clinical cohort study that serum level of miR-25 was significantly lower in SCA3/MJD patients (n=35) as compared to healthy controls (n=25) [51] (Table 2). This evidence concerns the gene ATXN3 and Spinocerebellar ataxia type 3.